Standout Papers
Citation Impact
Citing Papers
Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer
2014
Amplicon Mapping and Expression Profiling Identify the Fas-Associated Death Domain Gene as a New Driver in the 11q13.3 Amplicon in Laryngeal/Pharyngeal Cancer
2007
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions
2018
Stroke rehabilitation
2011 Standout
Head and neck squamous cell carcinoma
2020 Standout
Intensity-Modulated Radiotherapy of Head and Neck Cancer Aiming to Reduce Dysphagia: Early Dose–Effect Relationships for the Swallowing Structures
2007
Computed tomography imaging-guided radiotherapy by targeting upconversion nanocubes with significant imaging and radiosensitization enhancements
2013
The role of laser microsurgery in the treatment of laryngeal cancer
2007
Current clinical outcomes demand new treatment options for SCCHN
2005
Randomized Phase III Trial of Neoadjuvant Chemotherapy in Head and Neck Cancer: 10-Year Follow-Up
2004
Testicular Germ-Cell Cancer
1997 Standout
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 Standout
Chemoradiation for upper aerodigestive tract cancer: balancing evidence from clinical trials with individual patient recommendations
2003
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
2016 Standout
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
1998 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation
2008
Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence
2014
Improved Survival in Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome
1991
Transoral laser microsurgery as primary treatment for advanced‐stage oropharyngeal cancer: A united states multicenter study
2011
Drug penetration in solid tumours
2006 Standout
Loss of transforming growth factor-β type II receptor promotes metastatic head-and-neck squamous cell carcinoma
2006
Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
2016 Standout
Head and neck cancer
2008 Standout
Current concepts and new horizons in conservation laryngeal surgery: An important part of multidisciplinary care
2009
How to reduce radiation-related toxicity in patients with cancer of the head and neck
2006
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Head and Neck Cancer: Changing Epidemiology, Diagnosis, and Treatment
2008
Nasopharyngeal carcinoma
2019 Standout
Liposomal Daunorubicin (Daunoxome) in Combination with Cyclophosphamide, Vincristine and Prednisolone (COP-X) as Salvage Therapy in Poor-Prognosis Non-Hodgkins Lymphoma
2001
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Tumor Cell Metabolism: Cancer's Achilles' Heel
2008 Standout
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
2004 Standout
Nonurothelial Bladder Cancer and Rare Variant Histologies
2015
The molecular biology of head and neck cancer
2010 Standout
Locoregionally Advanced Head and Neck Cancer Treated With Primary Radiotherapy: A Comparison of the Addition of Cetuximab or Chemotherapy and the Impact of Protocol Treatment
2008
Advances in Radiation Therapy: Conventional to 3D, to IMRT, to 4D, and Beyond
2005
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
2009 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion
2009
Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma
2005
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data
2009
Induction Chemotherapy in Locally Advanced Head and Neck Cancer: A New Standard of Care?
2008
A functional integrin ligand on the surface of platelets: intercellular adhesion molecule-2.
1994
Nasopharyngeal carcinoma
2015 Standout
The chemoradiation paradigm in head and neck cancer
2007
Bladder cancer
2016 Standout
Chronic hepatitis B
2007 Standout
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Platelets in inflammation and atherogenesis
2005 Standout
Chronic hepatitis B: Update 2009 #
2009 Standout
Platelets and the immune continuum
2011 Standout
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
2007 Standout
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience
2004
State-of-the-art management of locally advanced head and neck cancer
2005
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
TGFβ in Cancer
2008 Standout
Testing treatment effects in the presence of competing risks
2005
The initial reactions of graphite and gold with blood
1997
Surface plasmon resonance and free oscillation rheometry in combination: a useful approach for studies on haemostasis and interactions between whole blood and artificial surfaces
2002 StandoutNobel
Transoral robotic surgery: A multicenter study to assess feasibility, safety, and surgical margins
2012
Laryngeal preservation in head and neck cancer: multidisciplinary approach
2006
TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group
2007
Complement-Independent, Peroxide-Induced Antibody Lysis of Platelets in HIV-1-Related Immune Thrombocytopenia
2001
Horizontal supraglottic partial laryngectomy for selected squamous carcinoma of the vallecula
2008
The pathophysiology and management of thrombotic thrombocytopenic purpura
1996
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
2010 Standout
Testicular germ cell tumors and human immunodeficiency virus infection: a report of 26 cases. Italian Cooperative Group on AIDS and Tumors.
1995
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
2013
Dysphagia treatment post stroke: a systematic review of randomised controlled trials
2008
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
2007 Standout
Real-World Evidence — What Is It and What Can It Tell Us?
2016 Standout
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications
2015 StandoutNobel
American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer
2006
Impact of Late Treatment-Related Toxicity on Quality of Life Among Patients With Head and Neck Cancer Treated With Radiotherapy
2008
Randomized Trial of Radiotherapy Versus Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy in Patients With American Joint Committee on Cancer/International Union Against Cancer Stage III and IV Nasopharyngeal Cancer of the Endemic Variety
2005
Chromophore-Modified Bisnaphthalimides: DNA Recognition, Topoisomerase Inhibition, and Cytotoxic Properties of Two Mono- and Bisfuronaphthalimides
2003
Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics
2014 Standout
Immune‐checkpoint molecules on regulatory T‐cells as a potential therapeutic target in head and neck squamous cell cancers
2020
Does Induction Chemotherapy Have a Role in the Management of Locoregionally Advanced Squamous Cell Head and Neck Cancer?
2006
Accelerated Radiotherapy With Carbogen and Nicotinamide for Laryngeal Cancer: Results of a Phase III Randomized Trial
2012
Head and Neck Cancer
2020 Standout
Paradigm Shift in the Treatment of Head and Neck Cancer: The Role of Neoadjuvant Chemotherapy
2005
Induction Chemotherapy for Head and Neck Cancer: Will History Repeat Itself?
2005
Long‐Term Quality of Life After Total Laryngectomy and Postoperative Radiotherapy Versus Concurrent Chemoradiotherapy for Laryngeal Preservation
2008
Prevention and Treatment of Dysphagia and Aspiration After Chemoradiation for Head and Neck Cancer
2006
Preliminary Results of Radiation Therapy Oncology Group 97-03: A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck
2004
Palifermin Reduces Severe Mucositis in Definitive Chemoradiotherapy of Locally Advanced Head and Neck Cancer: A Randomized, Placebo-Controlled Study
2011
Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer
2005
Infusional CHOP Chemotherapy (CVAD) With or Without Chemosensitizers Offers No Advantage Over Standard CHOP Therapy in the Treatment of Lymphoma: A Southwest Oncology Group Study
2001
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer
2012 Standout
The role of radiotherapy in cancer treatment
2005 Standout
Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high- risk" disease?
1994
Increased NBS1 Expression Is a Marker of Aggressive Head and Neck Cancer and Overexpression of NBS1 Contributes to Transformation
2006
The Expanding Role of Systemic Therapy in Head and Neck Cancer
2004
A meta-analysis comparing cisplatin-based to carboplatin-based chemotherapy in moderate to advanced squamous cell carcinoma of head and neck (SCCHN)
2016
Emergence of a Unique Group of Necrotizing Mycobacterial Diseases
1999
Risk factors for human disease emergence
2001 Standout
Tirapazamine, Cisplatin, and Radiation Versus Fluorouracil, Cisplatin, and Radiation in Patients With Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)
2004
Concurrent Chemoradiotherapy for Locally Advanced, Nonmetastatic, Squamous Carcinoma of the Head and Neck: Consensus, Controversy, and Conundrum
2006
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes
2015
Rattle-Structured Multifunctional Nanotheranostics for Synergetic Chemo-/Radiotherapy and Simultaneous Magnetic/Luminescent Dual-Mode Imaging
2013
Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
2017
Predictors of Competing Mortality in Advanced Head and Neck Cancer
2009
Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity
2014
Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck
2018
Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Radiation Therapy Oncology Group Phase II Trial 99-14
2005
Steroid–Free Chemotherapy Decreases Risk of Hepatitis B Virus (Hbv) Reactivation in Hbv–Carriers With Lymphoma
2003
Works of Andrea Leaf being referenced
An ECOG Phase II Study of Amonafide in Unresectable or Recurrent Carcinoma of the Head and Neck (PB390)
1997
Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer
2003 Standout
Infusional cyclophosphamide, doxorubicin, and etoposide in relapsed and resistant non-Hodgkin's lymphoma: evidence for a schedule-dependent effect favoring infusional administration of chemotherapy.
1993
Outcome of Salvage Total Laryngectomy Following Organ Preservation Therapy
2003
Infusional Cyclophosphamide, Doxorubicin and Etoposide in HIV-Related Non-Hodgkin's Lymphoma: a Follow-Up Report of a Highly Active Regimen
1994
Characterization and Outcomes of Small Cell Carcinoma of the Bladder Using the Surveillance, Epidemiology, and End Results Database
2012
Thrombotic Thrombocytopenic Purpura Associated with Human Immunodeficiency Virus Type 1 (HIV-1) Infection
1988
Mycobacterium marinum infection in a patient with the acquired immunodeficiency syndrome.
1994
Role of leuCAM integrins and complement in platelet-monocyte rosette formation induced by immune complexes of human immunodeficiency virus- type 1-immune thrombocytopenic purpura patients
1993
Role of leuCAM integrins and complement in platelet-monocyte rosette formation induced by immune complexes of human immunodeficiency virus- type 1-immune thrombocytopenic purpura patients
1993